David B. Kanne - Concepedia

Author

David B. Kanne

Also Known As

D. B. KANNE, D. KANNE, D. Kanne, D.B. Kanne, David B Kanne, David B. Kanne, David Kanne, David B. Kanne, Yvonne M. Saenger

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

University of California, Berkeley Aduro BioTech (United States)Lawrence Berkeley National Laboratory 490 BioTech (United States)Sidney Kimmel Comprehensive Cancer Center

About

David B. Kanne is an author at University of California, Berkeley specializing in biochemistry, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	11	11	623
2	Medicine	9	9	542
3	Natural Sciences	9	9	549
4	Engineering	3	3	290
5	Health Sciences	1	1	84

David B. Kanne

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity Leticia Corrales, Laura Hix Glickman, Sarah M. McWhirter, Cell Reports	2015	1.4K
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade Juan Fu, David B. Kanne, Meredith L. Leong, Science Translational Medicine	2015	681
Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity Kelsey E. Sivick, Anthony L. Desbien, Laura Hix Glickman, Cell Reports	2018	417
Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors Jason R. Baird, David J. Friedman, Benjamin Cottam, Cancer Research ImmunologyImmune RegulationPathologyImmunotherapeuticsImmune Cell Therapy	2015	232
The psoralen-DNA photoreaction. Characterization of the monoaddition products from 8-methoxypsoralen and 4,5',8-trimethylpsoralen David B. Kanne, Kenneth Straub, Henry Rapoport, Biochemistry	1982	194
Isolation and characterization of pyrimidine-psoralen-pyrimidine photodiadducts from DNA David B. Kanne, Kenneth Straub, John E. Hearst, Journal of the American Chemical Society Bioorganic ChemistryDnaEngineeringChemical AnalysisAltmetric Attention Score	1982	190
A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice Jeremy B. Foote, Marleen Kok, James M. Leatherman, Cancer Immunology Research	2017	148
Isolation and characterization of pyrimidine-psoralen photoadducts from DNA Kenneth Straub, David B. Kanne, John E. Hearst, Journal of the American Chemical Society	1981	133
STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection Erik Van Dis, Kimberly M. Sogi, Chris S. Rae, Cell Reports	2018	127
Structure of a psoralen-thymine monoadduct formed in photoreaction with DNA Seth Peckler, Bradford Graves, David B. Kanne, Journal of Molecular Biology Dna NanotechnologyDnaBiochemistryPhotochemistryNatural Sciences	1982	84

Page 1